“OK so apologize for technical difficulties, guys,” she said, adding. “We apologize, we don’t know what happened, we were hacked.”
The board meeting appeared to be back on track Wednesday night with Mujica Diaz texting The Post during the meeting, “We closed it down and started a new meeting.”Meeting participants were left shocked and disgusted.
X-rated hacks are nothing new in the Big Apple with many local government meetings being held remotely since the COVID-19 pandemic struck in March 2020. NYC Councilman Ari Kagan, who was on the CB 13 meeting over the phone and didn’t see the shocking moment, told The Post Wednesday night the same thing recently happened at a NYPD 62nd Precinct Community Council meeting.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Teenager stabbed to death on Brooklyn street: NYPD | amNewYorkThe teenager was transported to NYC Health & Hospitals/Kings County, where he was pronounced dead.
Read more »
PolaCon NYC is a Convention for Instant Film Photography FansPolaCon NYC is a three-day event coming in May that celebrates all things instant film.
Read more »
Drug for rare form of Lou Gehrig’s disease OK'd by FDAU.S. health regulators have approved a first-of-a-kind drug for a rare form of Lou Gehrig’s disease
Read more »
Drug for rare form of ALS disease OK’d by FDABiogen’s injectable drug is for patients with a rare genetic mutation that’s estimated to affect less than 500 people in the U.S.
Read more »
Adam Silver: NBA was OK with Rockets' decision to hire Ime UdokaNBA commissioner Adam Silver said the league had no objection to the Rockets' decision to...
Read more »
Drug for rare form of Lou Gehrig’s disease OK'd by FDAU.S. health regulators have approved a first-of-a-kind drug for a rare form of Lou Gehrig’s disease. The Food and Drug Administration approved Biogen's infused drug for patients with a rare genetic mutation that affects less than 500 people in the U.S. The drug is the first intended to treat an inherited form of ALS, or amyotrophic lateral sclerosis, which destroys nerve cells needed for basic functions. Tuesday's approval came despite a company study that failed to meet its goal of significantly slowing the disease. The drug did make a difference on laboratory measures of ALS. The FDA is requiring additional research to confirm the drug's benefit.
Read more »